Connect with us

Company News

Granules India Arm Gets USFDA Nod For Valganciclovir Hydrochloride Oral Solution

The US Food & Drug Administration (US FDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of Granules India Limited for Valganciclovir Hydrochloride for Oral Solution, 50 mg/mL. It is bioequivalent to the reference listed drug product (RLD), Valcyte for Oral Solution, 50 mg/mL, of Roche Palo Alto LLC.

Valganciclovir Hydrochloride solution is an antiviral medication used to treat cytomegalovirus infections.

Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.145.95 as compared to the previous close of Rs. 145.4. The total number of shares traded during the day was 36697 in over 744 trades.

The stock hit an intraday high of Rs. 148.4 and intraday low of 145.5. The net turnover during the day was Rs. 5369146.-Equity Bulls

Copyright © 2024 Medical Buyer

error: Content is protected !!